Get YouTube subscribers that watch and like your videos
Low Risk vs High Risk MDS - What's the Difference?
In this webinar, Dr. Marlise Luskin from Dana Farber Cancer Institute will define highrisk MDS versus lowrisk MDS, impact for patients and what treatment options are available.
This webinar is brought to you by the generous support of Celgene, Takeda and Jazz Pharmaceuticals.
Recommended
